SlideShare ist ein Scribd-Unternehmen logo

NAAF Scientific Update

•
•
National Alopecia Areata Foundation
National Alopecia Areata Foundation

Dr. Natasha Mesinkovska, NAAF’s Chief Scientific Officer, presented the latest progress of NAAF’s Treatment Development Program and how your involvement is critical to developing treatments for alopecia areata. In addition to overseeing NAAF’s research efforts, Dr. Mesinkovska is Director of Clinical Research in Dermatology at the University of California Irvine.

Gesundheit & Medizin
1 von 70
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION
NOT FOR DISTRIBUTION OR REPRODUCTION

Empfohlen

What's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataWhat's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataNational Alopecia Areata Foundation
 
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationPediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationNational Alopecia Areata Foundation
 
Treatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewTreatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewNational Alopecia Areata Foundation
 
Translating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsTranslating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsNational Alopecia Areata Foundation
 
Therapeutic advances in alopecia areata
Therapeutic advances in alopecia areataTherapeutic advances in alopecia areata
Therapeutic advances in alopecia areataNational Alopecia Areata Foundation
 
The therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisThe therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisNational Alopecia Areata Foundation
 
Epidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataEpidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataNational Alopecia Areata Foundation
 
The evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of diseaseThe evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of diseaseNational Alopecia Areata Foundation
 

Empfohlen

What's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataWhat's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataNational Alopecia Areata Foundation
 
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationPediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationNational Alopecia Areata Foundation
 
Treatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewTreatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewNational Alopecia Areata Foundation
 
Translating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsTranslating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsNational Alopecia Areata Foundation
 
Therapeutic advances in alopecia areata
Therapeutic advances in alopecia areataTherapeutic advances in alopecia areata
Therapeutic advances in alopecia areataNational Alopecia Areata Foundation
 
The therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisThe therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisNational Alopecia Areata Foundation
 
Epidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataEpidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataNational Alopecia Areata Foundation
 
The evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of diseaseThe evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of diseaseNational Alopecia Areata Foundation
 
The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataNational Alopecia Areata Foundation
 
Genetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout ReportGenetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout ReportNational Alopecia Areata Foundation
 
Health Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout ReportHealth Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout ReportNational Alopecia Areata Foundation
 
Clinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout ReportClinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout ReportNational Alopecia Areata Foundation
 
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...National Alopecia Areata Foundation
 
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsBroadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsNational Alopecia Areata Foundation
 
Willingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia AreataWillingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia AreataNational Alopecia Areata Foundation
 
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata EtiologyRare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata EtiologyNational Alopecia Areata Foundation
 
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...National Alopecia Areata Foundation
 
The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...National Alopecia Areata Foundation
 
2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First DayNational Alopecia Areata Foundation
 
NAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes ConsortiumNAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes ConsortiumNational Alopecia Areata Foundation
 
Standardizing Outcome Measures in Alopecia Areata
Standardizing Outcome Measures in Alopecia AreataStandardizing Outcome Measures in Alopecia Areata
Standardizing Outcome Measures in Alopecia AreataNational Alopecia Areata Foundation
 
Legacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program OverviewLegacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program OverviewNational Alopecia Areata Foundation
 
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...National Alopecia Areata Foundation
 
Alopecia Areata: A Patient's Perspective
Alopecia Areata: A Patient's PerspectiveAlopecia Areata: A Patient's Perspective
Alopecia Areata: A Patient's PerspectiveNational Alopecia Areata Foundation
 
Lessons from Psoriasis: What Can We Apply to Alopecia Areata?
Lessons from Psoriasis: What Can We Apply to Alopecia Areata?Lessons from Psoriasis: What Can We Apply to Alopecia Areata?
Lessons from Psoriasis: What Can We Apply to Alopecia Areata?National Alopecia Areata Foundation
 
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton MicroscopyIn Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton MicroscopyNational Alopecia Areata Foundation
 
Platelet-Rich Plasma in the Treatment of Alopecia Areata
Platelet-Rich Plasma in the Treatment of Alopecia AreataPlatelet-Rich Plasma in the Treatment of Alopecia Areata
Platelet-Rich Plasma in the Treatment of Alopecia AreataNational Alopecia Areata Foundation
 
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib CitrateLong Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib CitrateNational Alopecia Areata Foundation
 

Weitere ähnliche Inhalte

Mehr von National Alopecia Areata Foundation

The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataNational Alopecia Areata Foundation
 
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...National Alopecia Areata Foundation
 
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsBroadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsNational Alopecia Areata Foundation
 
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...National Alopecia Areata Foundation
 
The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...National Alopecia Areata Foundation
 
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...National Alopecia Areata Foundation
 
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton MicroscopyIn Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton MicroscopyNational Alopecia Areata Foundation
 
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib CitrateLong Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib CitrateNational Alopecia Areata Foundation
 

Mehr von National Alopecia Areata Foundation (20)

The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areata
 
Genetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout ReportGenetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout Report
 
Health Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout ReportHealth Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout Report
 
Clinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout ReportClinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout Report
 
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
 
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsBroadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial Participants
 
Willingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia AreataWillingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia Areata
 
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata EtiologyRare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
 
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
 
The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...
 
2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day
 
NAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes ConsortiumNAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes Consortium
 
Standardizing Outcome Measures in Alopecia Areata
Standardizing Outcome Measures in Alopecia AreataStandardizing Outcome Measures in Alopecia Areata
Standardizing Outcome Measures in Alopecia Areata
 
Legacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program OverviewLegacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program Overview
 
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
Development of a Novel Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of ...
 
Alopecia Areata: A Patient's Perspective
Alopecia Areata: A Patient's PerspectiveAlopecia Areata: A Patient's Perspective
Alopecia Areata: A Patient's Perspective
 
Lessons from Psoriasis: What Can We Apply to Alopecia Areata?
Lessons from Psoriasis: What Can We Apply to Alopecia Areata?Lessons from Psoriasis: What Can We Apply to Alopecia Areata?
Lessons from Psoriasis: What Can We Apply to Alopecia Areata?
 
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton MicroscopyIn Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
In Vivo Imaging in Alopecia Areata Patients Using Multiphoton Microscopy
 
Platelet-Rich Plasma in the Treatment of Alopecia Areata
Platelet-Rich Plasma in the Treatment of Alopecia AreataPlatelet-Rich Plasma in the Treatment of Alopecia Areata
Platelet-Rich Plasma in the Treatment of Alopecia Areata
 
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib CitrateLong Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
Long Term Treatment for Severe Alopecia Areata with Oral Tofacitinib Citrate
 

NAAF Scientific Update